Neopharma Technologies launch the World’s First Integration of a Rapid Drug Test with Cognitive Impairment Technology
**[Philadelphia, PA] – [September 3, 2024] ** – Neopharma Technologies is thrilled to announce a groundbreaking partnership with Impairment Science, Inc. to introduce the world’s first integration of a rapid drug test with cognitive impairment technology. This innovative solution addresses the growing demand for efficient and objective impairment measurement in the workplace and on the roadside.
Designed, in this era of cannabis legalization, specifically for employers grappling with the complexities of THC testing, this cutting-edge combination of technologies offers a dual advantage: it not only tests for the presence of drugs, including THC, but also provides a rapid, accurate, objective assessment of cognitive impairment. By combining these functions, this new combination is a powerfu...